Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-088447

Chief Financial Officer acquired 1,289 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goeltz II Robert C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-30 Grant or award : show line 1 in the form +1,289 $9.10 $11,723 7,289 D
Loading xslF345X03/doc1.xml…